Today is a memorable day for Leecan Pharmaceuticals! Terbutaline Sulfate Nebulised Inhalation Solution received the production approval, becoming the first approved product of LIC! Drug approval number: National Drug Code H20243490, listed trade name: Baizhang Ruijia.
The product applied for registration with the State Food and Drug Administration on 19 October 2022 and was formally accepted, and was approved on 16 April 2024, which is the strongest recognition and proof of the research and development, production and quality of Leecan Pharmaceuticals' products! This is the most powerful recognition and proof of R&D, production and quality of Leecan Pharmaceuticals products. The listing of this product will provide a safe and reliable new choice for patients' health, which is a solid step forward for “A century of Leecan ,blessing health”.
Since its establishment in May 2021, Leecan Pharmaceuticals, under the leadership of all leaders and the joint efforts of all staff, has taken ‘technology to enhance the quality of life’ as its mission, adhered to the original intention and marched forward with determination, and is committed to making Chinese people's own advanced inhalation formulations and complicated formulations with technological breakthroughs and innovation drive. Sweat and hard work have finally been rewarded; the hard work of ploughing has been rewarded today!
Thank you for the hard work and unremitting efforts of all the staff of Leecan, this achievement and joy belong to all the staff of Leecan! Looking to the future, the staff of Leecan will harvest more fruits of struggle together and witness more Leecan miracles! Leecan will be successful!
025-58181716
Share:
